Core Laboratories Inc. (NYSE:CLB) Shares Purchased by GAMMA Investing LLC

GAMMA Investing LLC boosted its position in Core Laboratories Inc. (NYSE:CLB) by 31.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,570 shares of the oil and gas company’s stock after purchasing an additional 857 shares during the quarter. GAMMA Investing LLC’s holdings in Core Laboratories were worth $61,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Morningstar Investment Services LLC raised its position in shares of Core Laboratories by 6.0% in the third quarter. Morningstar Investment Services LLC now owns 13,570 shares of the oil and gas company’s stock valued at $333,000 after buying an additional 764 shares during the last quarter. Quadrant Capital Group LLC raised its holdings in Core Laboratories by 84.0% in the 4th quarter. Quadrant Capital Group LLC now owns 3,370 shares of the oil and gas company’s stock valued at $60,000 after acquiring an additional 1,538 shares during the last quarter. Platinum Investment Management Ltd. lifted its stake in Core Laboratories by 43.8% in the 4th quarter. Platinum Investment Management Ltd. now owns 5,577 shares of the oil and gas company’s stock worth $98,000 after purchasing an additional 1,698 shares in the last quarter. Toroso Investments LLC boosted its holdings in shares of Core Laboratories by 6.9% during the 3rd quarter. Toroso Investments LLC now owns 38,348 shares of the oil and gas company’s stock worth $921,000 after purchasing an additional 2,480 shares during the last quarter. Finally, PNC Financial Services Group Inc. grew its position in shares of Core Laboratories by 72.7% in the third quarter. PNC Financial Services Group Inc. now owns 6,017 shares of the oil and gas company’s stock valued at $144,000 after purchasing an additional 2,533 shares in the last quarter. Hedge funds and other institutional investors own 97.81% of the company’s stock.

Core Laboratories Price Performance

NYSE:CLB opened at $18.56 on Monday. Core Laboratories Inc. has a 52 week low of $13.82 and a 52 week high of $27.94. The stock’s fifty day moving average is $17.58 and its two-hundred day moving average is $16.79. The company has a market capitalization of $870.46 million, a P/E ratio of 21.09, a P/E/G ratio of 1.15 and a beta of 2.39. The company has a quick ratio of 1.85, a current ratio of 2.68 and a debt-to-equity ratio of 0.68.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings data on Wednesday, April 24th. The oil and gas company reported $0.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.02. Core Laboratories had a net margin of 8.18% and a return on equity of 15.71%. The firm had revenue of $129.64 million for the quarter, compared to analyst estimates of $124.47 million. Equities analysts expect that Core Laboratories Inc. will post 0.73 EPS for the current year.

Core Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, May 28th. Investors of record on Monday, May 6th were issued a $0.01 dividend. The ex-dividend date of this dividend was Friday, May 3rd. This represents a $0.04 annualized dividend and a yield of 0.22%. Core Laboratories’s dividend payout ratio (DPR) is presently 4.55%.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Bank of America lowered their price objective on Core Laboratories from $17.00 to $16.00 and set an “underperform” rating on the stock in a research note on Monday, April 15th. Stifel Nicolaus upped their price objective on shares of Core Laboratories from $17.00 to $18.00 and gave the company a “hold” rating in a report on Friday, April 26th. Two analysts have rated the stock with a sell rating and three have given a hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $18.75.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.